CXCL9 and neoplasm: In breast cancer, NK cells take advantage of their own production of IFN-γ to enhance the secretion of chemokines CXCL9, CXCL10, and CXCL11 by tumor cells, which in turn accelerate the infiltration of CXCR3 expressing NK cells into the tumor site [65].